These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4965680)

  • 1. [Contribution to the study of memory in a group of senile patients (before and after treatment with a dihydrogenated ergot derivative)].
    Monteverdi T; Manara E
    Rass Neuropsichiatr; 1966; 20(1):41-8. PubMed ID: 4965680
    [No Abstract]   [Full Text] [Related]  

  • 2. Dihydrogenated alkaloids of ergot in geriatric patients: symptomatic treatment of cerebrovascular insufficiency.
    Kaye C
    Bol Asoc Med P R; 1972 Nov; 64(11):301-3. PubMed ID: 4205800
    [No Abstract]   [Full Text] [Related]  

  • 3. [Value of dihydrogenated ergot alkaloid combinations in the immediate postoperative period, particularly after extracorporeal circulation].
    Benhaim G; Daumet P
    Coeur Med Interne; 1973; 12(3):441-4. PubMed ID: 4200254
    [No Abstract]   [Full Text] [Related]  

  • 4. Dihydrogenated ergot alkaloids (Hydergine) and cerebrovascular insufficiency.
    Med Lett Drugs Ther; 1970 Mar; 12(6):27-8. PubMed ID: 4994841
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic correction of senile behavior characteristics with Wallerox. Contribution on experimental psychological geriatrics].
    Oswald WD; Müller-Egloff P; Becker E; Wilde M
    Munch Med Wochenschr; 1969 Jun; 111(26):1444-8. PubMed ID: 4980146
    [No Abstract]   [Full Text] [Related]  

  • 6. [Note on the use of dihydrogenated derivatives of ergotoxin (Hydergine) and their association with psychopharmacology in the treatment of aged neuropsychiatric patients].
    Bertolotti P; Spaggiari G
    Riv Sper Freniatr Med Leg Alien Ment; 1966 Oct; 90(5):1243-58. PubMed ID: 4968439
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the treatment of paresthesias in pregnancy with hydrogenated ergot alkaloids].
    Grigolo B
    Attual Ostet Ginecol; 1965; 11():Suppl:131-41. PubMed ID: 4957532
    [No Abstract]   [Full Text] [Related]  

  • 8. [Raubasine in combination with ergot alkaloid derivatives in the therapy of closed injuries of the brain].
    Stoppani L
    Arch Sci Med (Torino); 1965 Nov; 120(5):431-9. PubMed ID: 4956319
    [No Abstract]   [Full Text] [Related]  

  • 9. An ergot alkaloid preparation (Hydergine) in the treatment of presenile brain atrophy (Alzheimer's disease): case report.
    Burian E
    J Am Geriatr Soc; 1974 Mar; 22(3):126-8. PubMed ID: 4204771
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical examination of a combined antihypersensitive agent containing hydrogenated ergot alkaloid].
    Wanner J
    Schweiz Med Wochenschr; 1968 Aug; 98(32):1196-201. PubMed ID: 4974016
    [No Abstract]   [Full Text] [Related]  

  • 11. Oxytocic activity of two dihydrogenated ergot peptide alkaloids on the rabbit uterus in situ.
    Hool-Zulauf B; Stürmer E
    Arzneimittelforschung; 1977; 27(12):2323-5. PubMed ID: 414762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [1st experiences with a new hypotensive preparation combining a diuretic with ergot alkaloids].
    Basevi A; Tison M
    Boll Soc Ital Cardiol; 1966; 11(1):14-9. PubMed ID: 4957101
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of patients with cerebral and diffuse arteriosclerosis with hydergine].
    Avena G
    Hospital (Rio J); 1970 Sep; 78(3):901-28. PubMed ID: 4994595
    [No Abstract]   [Full Text] [Related]  

  • 14. [Wallerox increases cerebral circulation and heart capacity].
    Heynen U
    Z Allgemeinmed; 1971 Dec; 47(34):1823-5. PubMed ID: 5003212
    [No Abstract]   [Full Text] [Related]  

  • 15. [On treatment of acute cerebrovascular accidents].
    Berselli L; Ferracini R
    Clinica; 1965 Sep; 25(1):68-75. PubMed ID: 4954699
    [No Abstract]   [Full Text] [Related]  

  • 16. An ergot alkaloid preparation (hydergine) in geriatric therapy.
    Roubicek J; Geiger C; Abt K
    J Am Geriatr Soc; 1972 May; 20(5):222-9. PubMed ID: 4623679
    [No Abstract]   [Full Text] [Related]  

  • 17. Symptomatic treatment of cerebrovascular insufficiency with hydergine.
    Gerin J
    Curr Ther Res Clin Exp; 1969 Sep; 11(9):539-46. PubMed ID: 4980884
    [No Abstract]   [Full Text] [Related]  

  • 18. [Results of treatment with SEN DCS-1. Preliminary note on 24 patients].
    Pastor Franco A
    Rev Clin Esp; 1970 Aug; 118(4):359-64. PubMed ID: 4991986
    [No Abstract]   [Full Text] [Related]  

  • 19. [Sandoven-Sandoz in treatment of thromophlebitis and post-thrombophlebitic syndromes in surgical in-patients and out-patients].
    Umińska H
    Pol Tyg Lek; 1971 Jun; 26(23):870-2. PubMed ID: 4998207
    [No Abstract]   [Full Text] [Related]  

  • 20. Chronic cerebrovascular insufficiency in the elderly. Perspectives on treatment.
    Rosen HJ
    J Med Soc N J; 1972 May; 69(5):445-8. PubMed ID: 4623096
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.